Skip to main content

REVIEW article

Front. Endocrinol., 20 December 2011
Sec. Pituitary Endocrinology
This article is part of the Research Topic Craniopharyngioma – A childhood and adult disease with different characteristics View all 13 articles

Different Approaches in Radiation Therapy of Craniopharyngioma

  • Department of Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany

Radiation therapy is a cornerstone in the therapeutic management of craniopharyngioma. The close proximity to neighboring eloquent structures pose a particular challenge to radiation therapy. Modern treatment technologies including fractionated 3-D conformal radiotherapy, intensity modulated radiation therapy, and recently proton therapy are able to precisely cover the target while preserving surrounding tissue, Tumor controls between 80 and in access of 90% can be achieved. Alternative treatments consisting of radiosurgery, intracavitary application of isotopes, and brachytherapy also offer an acceptable tumor control and might be given in selected cases. More research is needed to establish the role of each treatment modality.

Introduction

Surgery and radiotherapy are the cornerstones in therapeutic management of craniopharyngioma. Radical excision is associated with a risk of mortality or morbidity particularly as hypothalamic damage, visual deterioration, and endocrine complication between 45 and 90% of cases. By contrast, recurrent disease after partial excision alone is observed between in 50 and 91% (Becker et al., 1999). Today less radical surgery in combination with radiation therapy are favored achieving a progression-free survival between 70 and 90% (Fahlbusch et al., 1999; Chiou et al., 2001; Tomita and Bowman, 2005).

New technologies are currently under investigation to achieve a better balance between tumor control and the risk for hazardous effects for surrounding eloquent structures such as the pituitary gland, hypothalamus, optic apparatus, and arteries at the base of the skull.

Role of Radiotherapy/Conventional Technologies

External fractionated radiotherapy is presently standard of care to achieve an optimal progression-free survival after non-radical excision (Wen et al., 1989; Hetelekidis et al., 1993; Merchant et al., 2002; Stripp et al., 2004; Karavitaki et al., 2005; Lin et al., 2008). An excellent long-term outcome of conventional radiotherapy was found in many retrospective series reporting 10 and 20 years progression-free survival up to 95 and 54% (Table 1).

TABLE 1
www.frontiersin.org

Table 1. Post-operative radiotherapy in craniopharyngioma/conventional techniques (tumor control and survival).

Modern Technologies in Radiation Therapy

Advances in radiation therapy technologies have opened up new approaches in the radio-oncological management of craniopharyngioma. The selection of the adequate treatment technology is of ongoing debate.

Fractionated Conformal Radiotherapy/Intensity Modulated Radiation Therapy

With the use of modern imaging technologies and treatment planning systems a precise coverage of the tumor area can be achieved by using stereotactic irradiation technologies. Stereotactic irradiation can be given in a single dose as stereotactic radiosurgery or in multiple doses as fractionated stereotactic radiotherapy. The modern systems permit an exact calculation of dose distribution within the tumor and provide a steeper dose gradient to surrounding normal tissue. If a cystic component is present, careful monitoring during radiotherapy is necessary (Winkfield et al., 2009). The results are shown in Table 2.

TABLE 2
www.frontiersin.org

Table 2. Results after modern external fractionated radiotherapy techniques.

Proton Therapy

The major advantage of proton therapy is the high degree of dose conformity to the target. Beltran et al. (2011) retrospectively evaluated proton treatment plans with IMRT plan. He concluded that compared with photon IMRT proton therapy has the potential to significantly reduce whole brain and body irradiation. Fitzek et al. treated 15 patients with craniopharyngioma with a mix of photon and protons. The tumor control rates at 5 and 10 years were 93 and 85%, respectively (Fitzek et al., 2006). Luu et al. (2006) treated 16 patients. Local control could be achieved in 14 of 15 patients (Luu et al., 2006).

Timing of Radiation Therapy

Often immediate post-operative radiation therapy is favored in order to obviate early tumor progression leading to a functional deterioration caused by tumor growth or the necessity for repeat surgery. Others favor a watch-and-wait strategy fearing the long-term adverse effects of radiation therapy. The recent series of Stripp et al. (2004), Tomita and Bowman (2005), and Moon et al. (2005) showed no differences between progression-free and overall survival between the different approaches (Table 3). However, in the recent series of Lin et al. (2008) early radiation therapy yielded a 100% local control rate at 10 years as compared with 32% when radiation therapy was performed at relapse.

TABLE 3
www.frontiersin.org

Table 3. Early versus delayed radiation therapy/impact on progression-free and overall survival.

Other Technologies

Radiosurgery

Stereotactic radiosurgery is an alternative to fractionated treatments in patients with craniopharyngioma harboring smaller lesions. The reported results of radiosurgery, however, suggest that tumor control is inferior to fractionated treatments and might carry the risk for optic neuropathies unless only smaller lesions are treated away from the optic apparatus (Tishler et al., 1993). Minniti et al. (2009) reviewed eight published series and found an average tumor control rate of 90% for solid tumors, 88% for cystic tumors, and 60% for mixed tumors (Table 4).

TABLE 4
www.frontiersin.org

Table 4. Outcome after stereotactic single dose radiosurgery in craniopharyngioma (Gamma Knife).

CyberKnife

CyberKnife includes a compact linear accelerator mounted on a robotic arm combined with the pair of diagnostic X-ray sources permitting an online reproducibility of the incident beams and a subsequent adjustment of the beam with a precision below 1 mm. Lee et al. reported results obtained in 16 patients treated for residual recurrent craniopharyngioma Tumor shrinkage was achieved in 7 of these 11 patients and tumor control in another 3 patients. The overall tumor control was achieved in 91% of patients without complications (Lee et al., 2008).

Interstitial Brachytherapy

There is one report from Barlas et al. (2000) in two patients in whom iodine125-seeds were implanted delivering a dose of 67 and 60 Gy to tumor periphery. Response was partially observed in one and tumor completely resolved in the other patient 24 months after treatment. Radiation induced toxicity or recurrence has not been reported 6 years after treatment.

Intracavitary Application of Isotopes

Approximately 90% of craniopharyngioma display a cystic component often leading to a space occupying clinically relevant effect. There are different series reporting on the intracavitary application of different isotopes such as Rhenium186, Yttrium90, or Phosporus32. The nuclides emit β-rays with a therapeutic range within only a few millimeters. Response rates and cyst controls can be achieved in more than 80% of case. Tumors with a solid component, however, are insufficiently controlled (Voges et al., 1997; Hasegawa et al., 2004). Deterioration of visual function due to ionizing irradiation of the nuclides can occur (Table 5).

TABLE 5
www.frontiersin.org

Table 5. Intracavitary instillation of radionuclides/impact on tumor control and visual function (modified according to Derrey et al., 2008).

Conclusion

Standard treatments today consist of fractionated external irradiation therapy. The recent developments in modern treatment technologies permit an exact delineation of target and non-target surrounding normal tissue (Merchant et al., 2006). Tumor control and overall survival might be improved as compared with the excellent results obtained with conventional treatments at shorter follow-up periods. Longer follow-up periods, however, are warranted. Today the 5-year progression-free survival after modern fractionated irradiation is in the range between 80 and 100%. Good results are achieved with a combined approach (surgery + radiation therapy) using standard fractionation. The recently introduced proton therapy opens up the possibility for a better sparing of normal surrounding tissue. Presently data are, however, limited and the expected improvement of functional outcome remains yet to be proven.

Post-operative radiation therapy is superior to surveillance after non-radical resection in terms of progression-free survival. The impact of different timing on functional outcome is still unknown. The current prospective German study Craniopharyngioma 2007 is addressing this issue in a randomized prospective study.

Radiosurgery as an option for circumscribed small lesions away from the optic apparatus is an attractive option because normal surrounding tissue is excellently spared. Single dose radiotherapy is, however, associated with an inferior tumor control according to retrospective data. CyberKnife as a new technological development utilizing image guided high precision stereotactic radiotherapy is able to use the radiobiologically advantageous fractionation concept. Interstitial treatments like the intracystic application of radioactive colloids might be used in selected cases in which only cystic tumors are present. It is, however, more a historical experience and should not be favored in the area of modern treatment technologies. Brachytherapy is of limited importance and the experiences so far obtained are very scarce. Minimizing the dose to non-target tissue will be the future step to reduce the risk for late effects. Reproducible data in prospective settings including neurocognitive function, quality of life, visual, and endocrinological function are still missing and require further research and evaluation. Table 6 gives an overview of the current technologies.

TABLE 6
www.frontiersin.org

Table 6. Advantages and disadvantages of modern treatment technologies in radiotherapy of craniopharyngioma.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Amendola, B. E., Wolf, A., Coy, S. R., and Amendola, M. A. (2003). Role of radiosurgery in craniopharyngiomas: a preliminary report. Med. Pediatr. Oncol. 41, 123–127.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Barlas, O., Bayindir, C., and Can, M. (2000). Interstitial irradiation for craniopharyngioma. Acta Neurochir. (Wien) 142, 389–395.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Becker, G., Kortmann, R. D., Skalej, M., and Bamberg, M. (1999). The role of radiotherapy in the treatment of craniopharyngioma – indications, results, side effects. Front. Radiat. Ther. Oncol. 33, 100–113.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Beltran, C., Roca, M., and Merchant, T. E. (2011). On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int. J. Radiat. Oncol. Biol. Phys. [Epub ahead of print].

CrossRef Full Text

Blackburn, T. P., Doughty, D., and Plowman, P. N. (1999). Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br. J. Neurosurg. 13, 359–365.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Carmel, P. W., Antunes, J. L., and Chang, C. H. (1982). Craniopharyngiomas in children. Neurosurgery 11, 382–389.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Chiou, S. M., Lunsford, L. D., Niranjan, A., Kondziolka, D., and Flickinger, J. C. (2001). Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro-oncology 3, 159–166.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Chung, W. Y., Pan, D. H., Shiau, C. Y., Guo, W. Y., and Wang, L. W. (2000). Gamma knife radiosurgery for craniopharyngiomas. J. Neurosurg. 93(Suppl. 3), 47–56.

Pubmed Abstract | Pubmed Full Text

Combs, S. E., Thilmann, C., Huber, P. E., Hoess, A., Debus, J., and Schulz-Ertner, D. (2007). Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer 109, 2308–2314.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Derrey, S., Blond, S., Reyns, N., Touzet, G., Carpentier, P., Gauthier, H., and Dhellemmes, P. (2008). Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery 63, 1045–1052; discussion 1052–1053.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Fahlbusch, R., Honegger, J., Paulus, W., Huk, W., and Buchfelder, M. (1999). Surgical treatment of craniopharyngiomas: experience with 168 patients. J. Neurosurg. 90, 237–250.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Fitzek, M. M., Linggood, R. M., Adams, J., and Munzenrider, J. E. (2006). Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int. J. Radiat. Oncol. Biol. Phys. 64, 1348–1354.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Flickinger, J. C., Lunsford, L. D., Singer, J., Cano, E. R., and Deutsch, M. (1990). Megavoltage external beam irradiation of craniopharyngiomas: analysis of tumor control and morbidity. Int. J. Radiat. Oncol. Biol. Phys. 19, 117–122.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Habrand, J. L., Ganry, O., Couanet, D., Rouxel, V., Levy-Piedbois, C., Pierre-Kahn, A., and Kalifa, C. (1999). The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int. J. Radiat. Oncol. Biol. Phys. 44, 255–263.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Hasegawa, T., Kondziolka, D., Hadjipanayis, C. G., and Lunsford, L. D. (2004). Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54, 813–822.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Hashizume, C., Mori, Y., Kobayashi, T., Shibamoto, Y., Nagai, A., and Hayashi, N. (2010). Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways. J. Neurooncol. 98, 239–247.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Hetelekidis, S., Barnes, P. D., Tao, M. L., Fischer, E. G., Schneider, L., Scott, R. M., and Tarbell, N. J. (1993). 20-Year experience in childhood craniopharyngioma. Int. J. Radiat. Oncol. Biol. Phys. 27, 189–195.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Kanesaka, N., Mikami, R., Nakayama, H., Nogi, S., Tajima, Y., Nakajima, N., Wada, J., Miki, T., Haraoka, J., Okubo, M., Sugahara, S., and Tokuuye, K. (2011). Preliminary results of fractionated stereotactic radiotherapy after cyst drainage for craniopharyngioma in adults. Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2011.05.014. [Epub ahead of print].

CrossRef Full Text

Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B., Richards, P., Ansorge, O., Shine, B., Turner, H. E., and Wass, J. A. (2005). Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin. Endocrinol. (Oxf.) 62, 397–409.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Kobayashi, T., Kida, Y., Mori, Y., and Hasegawa, T. (2005). Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J. Neurosurg. 103(Suppl.), 482–488.

Lee, M., Kalani, M. Y., Cheshier, S., Gibbs, I. C., Adler, J. R., and Chang, S. D. (2008). Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas. Neurosurg. Focus 24, E4.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Lin, L. L., El Naqa, I., Leonard, J. R., Park, T. S., Hollander, A. S., Michalski, J. M., and Mansur, D. B. (2008). Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J. Neurosurg. Pediatr. 1, 126–130.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Luu, Q. T., Loredo, L. N., Archambeau, J. O., Yonemoto, L. T., Slater, J. M., and Slater, J. D. (2006). Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. 12, 155–159.

Pubmed Abstract | Pubmed Full Text

Mark, R. J., Lutge, W. R., Shimizu, K. T., Tran, L. M., Selch, M. T., and Parker, R. G. (1995). Craniopharyngioma: treatment in the CT and MR imaging era. Radiology 197, 195–198.

Pubmed Abstract | Pubmed Full Text

Merchant, T. E., Kiehna, E. N., Kun, L. E., Mulhern, R. K., Li, C., Xiong, X., Boop, F. A., and Sanford, R. A. (2006). Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J. Neurosurg. 104, 94–102.

Pubmed Abstract | Pubmed Full Text

Merchant, T. E., Kiehna, E. N., Sanford, R. A., Mulhern, R. K., Thompson, S. J., and Wilson, M. W. (2002). Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int. J. Radiat. Oncol. Biol. Phys. 53, 533–542.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Minniti, G., Esposito, V., Amichetti, M., and Enrici, R. M. (2009). The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg. Rev. 32, 125–132.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Minniti, G., Saran, F., Traish, D., Soomal, R., Sardell, S., Gonsalves, A., Ashley, S., Warrington, J., Burke, K., Mosleh-Shirazi, A., and Brada, M. (2007). Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother. Oncol. 82, 90–95.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Mokry, M. (1999). Craniopharyngiomas: a six year experience with Gamma Knife radiosurgery. Stereotact. Funct. Neurosurg. 72(Suppl. 1), 140–149.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Moon, S. H., Kim, I. H., Park, S. W., Kim, I., Hong, S., Park, C. I., Wang, K. C., and Cho, B. K. (2005). Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas – a study in single institute. Childs Nerv. Syst. 21, 799–807.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Pemberton, L. S., Dougal, M., Magee, B., and Gattamaneni, H. R. (2005). Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother. Oncol. 77, 99–104.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Prasad, D., Steiner, M., and Steiner, L. (1995). Gamma knife surgery for craniopharyngioma. Acta Neurochir. (Wien) 134, 167–176.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Rajan, B., Ashley, S., Gorman, C., Jose, C. C., Horwich, A., Bloom, H. J., Marsh, H., and Brada, M. (1993). Craniopharyngioma – a long-term results following limited surgery and radiotherapy. Radiother. Oncol. 26, 1–10.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Regine, W. F., Mohiuddin, M., and Kramer, S. (1993). Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiat. Oncol. 27, 13–21.

CrossRef Full Text

Selch, M. T., DeSalles, A. A., Wade, M., Lee, S. P., Solberg, T. D., Wallace, R. E., Ford, J. M., Rubino, G., Cabatan-Awang, C., and Withers, H. R. (2002). Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas. Technol. Cancer Res. Treat. 1, 51–60.

Pubmed Abstract | Pubmed Full Text

Stripp, D. C., Maity, A., Janss, A. J., Belasco, J. B., Tochner, Z. A., Goldwein, J. W., Moshang, T., Rorke, L. B., Phillips, P. C., Sutton, L. N., and Shu, H. K. (2004). Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int. J. Radiat. Oncol. Biol. Phys. 58, 714–720.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Sung, D. I., Chang, C. H., and Harisiadis, L. (1981). Treatment results of craniopharyngiomas. Cancer 47, 847–852.

CrossRef Full Text

Tishler, R. B., Loeffler, J. S., Lunsford, L. D., Duma, C., Alexander, E. III, Kooy, H. M., and Flickinger, J. C. (1993). Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 27, 215–221.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Tomita, T., and Bowman, R. M. (2005). Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv. Syst. 21, 729–746.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Ulfarsson, E., Lindquist, C., Roberts, M., Rahn, T., Lindquist, M., Thoren, M., and Lippitz, B. (2002). Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J. Neurosurg. 97(Suppl.), 613–622.

Pubmed Abstract | Pubmed Full Text

Varlotto, J. M., Flickinger, J. C., Kondziolka, D., Lunsford, L. D., and Deutsch, M. (2002). External beam irradiation of craniopharyngiomas: long-term analysis of tumor control and morbidity. Int. J. Radiat. Oncol. Biol. Phys. 54, 492–499.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Voges, J., Sturm, V., Lehrke, R., Treuer, H., Gauss, C., and Berthold, F. (1997). Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40, 263–270.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Wen, B. C., Hussey, D. H., Staples, J., Hitchon, P. W., Jani, S. K., Vigliotti, A. P., and Doornbos, J. F. (1989). A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. Int. J. Radiat. Oncol. Biol. Phys. 16, 17–24.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Winkfield, K. M., Linsenmeier, C., Yock, T. I., Grant, P. E., Yeap, B. Y., Butler, W. E., and Tarbell, N. J. (2009). Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 73, 716–721.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Yu, X., Liu, Z., and Li, S. (2000). Combined treatment with stereotactic intracavitary irradiation and gamma knife surgery for craniopharyngiomas. Stereotact. Funct. Neurosurg. 75, 117–122.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Keywords: craniopharyngioma, radiotherapy, post-operative

Citation: Kortmann R-D (2011) Different approaches in radiation therapy of craniopharyngioma. Front. Endocrin. 2:100. doi: 10.3389/fendo.2011.00100

Received: 29 July 2011; Paper pending published: 07 September 2011;
Accepted: 28 November 2011; Published online: 20 December 2011.

Edited by:

Hermann Lothar Mueller, Klinikum Oldenburg gGmbH, Germany

Reviewed by:

Ya-Xiong Tao, Auburn University, USA
Frederic Castinetti, Assistance Publique Hopitaux de Marseille, France
Alapetite Claire, Institut Curie, France

Copyright: © 2011 Kortmann. This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.

*Correspondence: Rolf-Dieter Kortmann, Department of Radiation Therapy and Radio-oncology, University of Leipzig, Stephanstr. 9a, 04103 Leipzig, Germany. e-mail: rolf-dieter.kortmann@medizin.uni-leipzig.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.